• MOG (35-55) Peptide: Precision Tool for Autoimmune Encephalo

  2026-05-13

  MOG (35-55) Peptide empowers researchers to generate highly reproducible autoimmune encephalomyelitis models, advancing both mechanistic and translational multiple sclerosis studies. Leveraging recent insights into PARP7-STAT1/STAT2 signaling, this peptide offers clear advantages for dissecting neuroinflammation and testing novel therapeutic strategies.

• EDI3 Inhibition Overcomes HER2 Therapy Resistance in ER-HER2

  2026-05-13

  Keller et al. reveal that targeting the glycerophosphodiesterase EDI3 reduces viability and tumor growth in ER-HER2+ breast cancer cells resistant to HER2-targeted therapies. This study highlights EDI3 as a promising metabolic vulnerability with translational potential for overcoming therapeutic resistance in aggressive breast cancer subtypes.

• Quercetin as a Multi-Target PI3K Inhibitor: New Horizons in

  2026-05-12

  Explore how Quercetin, a potent PI3K inhibitor, orchestrates mitochondrial apoptosis and ferroptosis suppression. This article delivers advanced mechanistic insights for cancer research and cell death assays, grounded in the latest evidence on p53 modulation and lipid peroxidation control.

• BRD4770: G9a Histone Methyltransferase Inhibitor for Cancer

  2026-05-12

  BRD4770 empowers precision interrogation of epigenetic regulation in cancer models by reliably inhibiting G9a-mediated H3K9 methylation. This guide maps out workflow enhancements, advanced use-cases, and troubleshooting strategies, unlocking robust senescence and proliferation assays for cancer biology research.

• Pregnenolone Carbonitrile in Hepatic Detoxification & Fibros

  2026-05-11

  Pregnenolone Carbonitrile offers robust, reproducible activation of rodent PXR, making it a gold-standard tool for studying xenobiotic metabolism, cytochrome P450 CYP3A induction, and the inhibition of hepatic fibrosis. This guide details advanced workflows, troubleshooting strategies, and the latest cross-domain findings to help researchers maximize data consistency and translational impact.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Protocols & Adva

  2026-05-11

  The One-step TUNEL Cy3 Apoptosis Detection Kit empowers rapid, reproducible DNA fragmentation analysis in both tissue sections and cultured cells. Leveraging streamlined terminal deoxynucleotidyl transferase (TdT) labeling and Cy3 fluorescence, researchers can dissect apoptosis with clarity—even in challenging models like hepatic carcinoma or pyroptosis.

• Sulfo-NHS-LC-Biotin for Cell Surface Protein Biotinylation

  2026-05-10

  Sulfo-NHS-LC-Biotin enables selective, covalent labeling of primary amines on proteins, particularly for cell surface biotinylation where membrane impermeability is required. This reagent is best suited for workflows that demand stable amide bond formation in aqueous conditions; it should not be used where reversible labeling or intracellular biotinylation is needed.

• Cholesterol Impedes Intracellular Trafficking of Lipid Nanop

  2026-05-09

  Luo et al. (2025) reveal that elevated cholesterol in lipid nanoparticles (LNPs) causes their aggregation in peripheral early endosomes, hindering effective intracellular trafficking and nucleic acid delivery. This mechanistic insight refines strategies for optimizing LNP formulations in gene delivery and vaccine platforms.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Optimized Delivery & Immunot

  2026-05-09

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) unlocks precision cytokine modulation for immunotherapy and gene expression studies by combining advanced mRNA chemistry with the latest in tissue-targeted delivery. This guide connects actionable workflow enhancements to recent breakthroughs in virus-mimicking nanoparticle engineering, with practical troubleshooting tips for reproducible results.

• Alda 1 (SKU B5508): Reliable ALDH2 Activation for Cardiac Re

  2026-05-08

  This article provides an in-depth, scenario-driven analysis of how Alda 1 (SKU B5508), a potent ALDH2 activator, addresses key challenges in cell viability, proliferation, and cytotoxicity assays for cardiac ischemia and aldehyde detoxification research. By integrating validated literature, practical optimization strategies, and vendor selection guidance, it demonstrates Alda 1’s reproducibility and translational value for biomedical researchers.

• Fludarabine as a DNA Synthesis Inhibitor: Advanced Oncology

  2026-05-07

  Fludarabine’s dual role as a DNA synthesis inhibitor and immune modulator is unlocking new precision in leukemia and multiple myeloma research. This article details optimized workflows, troubleshooting strategies, and actionable insights from recent immuno-oncology breakthroughs, empowering researchers to drive robust, reproducible discoveries.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye in Protein

  2026-05-07

  Sulfo-Cy3 NHS Ester stands apart as a hydrophilic fluorescent dye, enabling robust protein labeling—even for low-solubility targets—without organic co-solvents. Its minimized quenching and superior water solubility translate into sharper, more reliable results for cutting-edge vascular and cell biology research.

• Disodium Bicinchoninate: Water-Soluble Reagent for Molecular

  2026-05-06

  Disodium bicinchoninate (sodium [2,2'-biquinoline]-4,4'-dicarboxylate) offers researchers a robust, water-soluble small molecule biochemical reagent for optimizing chelation-based assays in molecular biology and cell research. Unique solubility, workflow compatibility, and minimal organic solvent interference set it apart for advanced, reproducible applications.

• Precision Apoptosis Quantification: One-step TUNEL Cy3 Kit i

  2026-05-06

  Explore how the One-step TUNEL Cy3 Apoptosis Detection Kit enables precise, translational quantification of apoptosis in liver ischemia-reperfusion injury models. This article uniquely contextualizes TdT-based DNA fragmentation assays within current advances in hepatoprotection and clinical research.

• Fosinopril Sodium in Cardiovascular Research: ACE Inhibitor

  2026-05-05

  Fosinopril sodium offers unique advantages for modeling hypertension and modulating renal hemodynamics, thanks to its phosphinic acid structure and dual elimination. This article details actionable workflows, troubleshooting strategies, and evidence-backed protocol enhancements for translational cardiovascular research using APExBIO’s trusted formulation.

16311 records 1/1088 page Next 12345 下5页 Last page